These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 6260657

  • 41. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM, Huang ZY, Gallagher JR, Lin Y, Lou H, Whitbeck JC, Wald A, Cohen GH, Eisenberg RJ.
    J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
    [Abstract] [Full Text] [Related]

  • 42. Crossed immunoelectrophoretic analysis and viral neutralizing activity of five monospecific antisera against five different herpes simplex virus glycoproteins.
    Vestergaard BF, Norrild B.
    IARC Sci Publ (1971); 1978 Sep; (24 Pt 1):225-34. PubMed ID: 221329
    [Abstract] [Full Text] [Related]

  • 43. The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections.
    Eberle R, Mou SW, Zaia JA.
    J Med Virol; 1985 Jun; 16(2):147-62. PubMed ID: 2409225
    [Abstract] [Full Text] [Related]

  • 44. Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems.
    Mohamedi SA, Brewer JM, Alexander J, Heath AW, Jennings R.
    Vaccine; 2000 Apr 14; 18(20):2083-94. PubMed ID: 10715522
    [Abstract] [Full Text] [Related]

  • 45. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity.
    Sanchez-Pescador L, Paz P, Navarro D, Pereira L, Kohl S.
    J Infect Dis; 1992 Sep 14; 166(3):623-7. PubMed ID: 1380051
    [Abstract] [Full Text] [Related]

  • 46. Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera.
    Eberle R, Courtney RJ.
    Infect Immun; 1981 Mar 14; 31(3):1062-70. PubMed ID: 6262247
    [Abstract] [Full Text] [Related]

  • 47. Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies.
    Fuller AO, Spear PG.
    J Virol; 1985 Aug 14; 55(2):475-82. PubMed ID: 2991570
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Neutralizing activity of antibodies against the major herpes simplex virus type 1 glycoproteins.
    Eing BR, Kühn JE, Braun RW.
    J Med Virol; 1989 Jan 14; 27(1):59-65. PubMed ID: 2466100
    [Abstract] [Full Text] [Related]

  • 51. Limiting dilution analysis of specific in vitro anti-herpes simplex virus antibody production by human lymphocytes.
    Yasukawa M, Kobayashi Y.
    Clin Exp Immunol; 1987 Apr 14; 68(1):39-47. PubMed ID: 2820632
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Detection in antisera of antibodies that cross-react with herpes simplex virus type 1 glycoprotein gC.
    Zweig M, Heilman CJ, Bladen SV, Showalter SD, Hampar B.
    Infect Immun; 1983 Aug 14; 41(2):482-7. PubMed ID: 6307870
    [Abstract] [Full Text] [Related]

  • 54. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
    Glorioso J, Szczesiul MS, Marlin SD, Levine M.
    Virology; 1983 Apr 15; 126(1):1-18. PubMed ID: 6189286
    [Abstract] [Full Text] [Related]

  • 55. Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D.
    Ghiasi H, Nesburn AB, Kaiwar R, Wechsler SL.
    Arch Virol; 1991 Apr 15; 121(1-4):163-78. PubMed ID: 1662037
    [Abstract] [Full Text] [Related]

  • 56. Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes.
    Kari B, Lussenhop N, Goertz R, Wabuke-Bunoti M, Radeke R, Gehrz R.
    J Virol; 1986 Nov 15; 60(2):345-52. PubMed ID: 3021969
    [Abstract] [Full Text] [Related]

  • 57. Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Initial analysis of its biochemical and immunological properties.
    Ghiasi H, Kaiwar R, Nesburn AB, Wechsler SL.
    Virus Res; 1992 Jan 15; 22(1):25-39. PubMed ID: 1311136
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Du R, Wang L, Xu H, Wang Z, Zhang T, Wang M, Ning Y, Deng F, Hu Z, Wang H, Li Y.
    Antiviral Res; 2017 Nov 15; 147():131-141. PubMed ID: 29061442
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.